Christoph Samuel Ziegler
CIK: 0002123272
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRXA
Veraxa Biotech AG - Post de-SPAC
Director
Discretionary Trading P&L
Holdings
About Ziegler Christoph Samuel
Ziegler Christoph Samuel (SEC CIK 0002123272) files insider reports with the SEC as Director of Veraxa Biotech AG - Post de-SPAC (VRXA).
Signal8 holds 2 ownership filings by Ziegler Christoph Samuel (1 Form 3, 1 Form 4), filed between Jun 10, 2026 and Oct 21, 2026. Those filings report 1 transaction, the latest on Oct 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ziegler Christoph Samuel's filings is in ZURICH.
Recent filings by Ziegler Christoph Samuel
- Oct 20, 2026: Open-market purchase of VRXA shares (Form 4, code P).
Other insiders filing for Veraxa Biotech AG - Post de-SPAC (VRXA)
- Gruninger Marc, Director
- Hosseinion Warren, Director
- Willener Raju Sudir, Chief Financial Officer
- von Halem Carl, Interim CFO
- Baumann Oliver Rolf, Director
- Antz Christoph Rudiger, Chief Executive Officer